Good Lifestyle

Johnson's Covid Vaccine & Johnson faced his fair share of problems, frompotential to cause blood clots to hislow efficiency rate. Now, managers say that the dose plan could also have another new side effect. On Monday, July 12, the disease control and prevention centers (CDC) and the Food and Drug Administration (FDA) published a new warning on a potential reaction to Johnson & Johnson vaccine, which is cropped among a certain demographics, of weeks after they had it.

RELATED:If you have Johnson & Johnson, how long are you really protected.

The FDA has updated the Johnson & Johnson Covid Vaccine Label to warn of thePossible increased risk of Guillain-Barré syndrome. "Today, the FDA announces the revisions of the vaccine fact sheets and the Vaccine Provider for the Johnson & Johnson Covid-19 Vaccine (Janssen) to include information about aobserved an increased risk of Guillain-Barré syndrome (GBS) After vaccination, "the agency stated in a statement sent to CNN.

According to the Mayo Clinic, Guillain-Barre's syndrome is a "rare disorder In which the immune system of your body attacks your nerves. The first symptom of the disease is often a weakness and tingling in your extremities. The disease can lead to muscle weakness and paralysis sometimes, but the vast majority of patients restore.

The updated label on the Johnson & Johnson vaccine said: "Reports of adverse events after using the Janssen Covid-19 vaccine under an emergency authorization suggests an increased risk of Guillain-Barré syndrome. During the 42 days following vaccination. "

The CDC stated in a statement to the associated press it received reports that100 people who had the Johnson & Johnson vaccine Developed Guillain-Barré syndrome. Although this is only a tiny fraction of nearly 13 million people in the United States who received the Johnson & Johnson vaccine, it is still remarkable. The PA reports that most cases of Guillain-Barré syndrome after Johnson & Johnson's inoculation were observed two weeks later for men over 50. But as indicated the warning of the FDA, it could appear up to six weeks later.

RELATED:For more information up to date, sign up for our daily newsletter.

In the spring, shortly after the Johnson & Johnson vaccine received an emergency use of the FDA, anecdotal reports increased.Numbness and tingling in the hands and fingers. In a case study published in April in the journalNeurology, scientists have examined an instance of a 60-year-old woman whoReceived Johnson & Johnson Vaccine During a trial of 2020 December and developed Guillain-Barré syndrome, but recovered.

"The case of our report may have been a coincidence"Anthony Amato, MD, a neurologist of Harvard Medical School in Boston and author of the author of the case study, told health at the time. "With about one billion people around the world should be vaccinated against Covid-19, we expect it to beThousands of Guillain-Barré Syndrome Cases This will happen around the time of vaccination only by coincidence. On the basis of experience with other vaccination and data initiatives in the unfavorable monitoring systems of CVIV-19 vaccines collected so far we are certain that the benefits of vaccination outweigh the risks of COVID-19 infection. "

RELATED:If you take these medications, you may not have any post-vaccine antibodies..

According to the AP, the CDC stated that the other US Covid vaccines do not show a risk of causing Guillain-Barré syndrome. In December, theCDC Guidelines on Covid Vaccines, which only included Pfizer and moderna at that time, said: "To date, no case of Guillain-Barre Syndrome (GBS) has been reported as a result of vaccination among participants in the tests Covid-19 mRNA vaccine clinics, referring to Pfizer and Moderna. "Within a few exceptions, the Independent Advisory Committee on Immunization Practices (ACIP)General Guidelines for Best Practices for ImmunizationDo not include a history of GBS in order to precaution with vaccination with other vaccines, "said the agency. Of course, Johnson & Johnson was not yet approved for emergency use.

The Washington Postreports that the CDC ACIP plans to discuss thePotential link between Guillain-Barré syndrome And Johnson & Johnson vaccine at a future meeting.

The CDC shows about 3,000 to 6,000 peopleDevelop Guillain-Barré syndromeevery year. It can be triggered by various infections such as influenza, cytomegalovirus and Zika virus. However, there were also cases where people develop the disease after receiving vaccines.

RELATED:If you did this after your first shot, you are at risk of the delta variant.